scholarly journals WHO and the Global Outbreak and Response Network: coordinated surveillance to combat infectious diseases

2002 ◽  
Vol 6 (3) ◽  
Author(s):  
B Twisselmann

On 5 December 2001 Eurosurveillance Weekly reported on the second meeting of the World Health Organization (WHO)’s Global Outbreak and Response Network (GOARN), which was held on 29-30 November in Geneva (1). A review in the Lancet Infectious Diseases provides extensive background reading to this WHO venture, which was inaugurated in April 2000 by WHO’s Department of Communicable Disease Surveillance and Response (CSR, http://www.who.int/emc/pdfs/csr%20strategyE.pdf) to respond to the resurgence of the microbial threat

2001 ◽  
Vol 5 (49) ◽  
Author(s):  
A Moren ◽  
A Nicoll

The second meeting of the Global Outbreak and Response Network (GOARN) was held on 29-30 November 2001 in Geneva, Switzerland. More than 120 attendants represented 82 institutions and governments. The network was formed in April 2000 by the Department of Communicable Disease Surveillance and Response of the World Health Organization (WHOCSR) (http://www.who.int/emc/pdfs/csr%20strategyE.pdf) and partners as an international collaboration of technical associates in the area of epidemic alert and response, including relevant public sector, intergovernmental, and non-governmental organisations, and the private sector (http://www.who.int/emc/pdfs/network.pdf).


2019 ◽  
Vol 21 (4) ◽  
Author(s):  
Isfandari Siti ◽  
Betty Roosihermiatie

Intersectoral approach is essential to develop program for people with disability in Indonesia. Coordination across ministries are necessary to manage this issue. The planning, provision and monitoring of medical and support services as well as program for population groups with disability may require assessment. Purpose of this study is to assess disability in Indonesia. Methods: performing analysis of disability data from 2013 Indonesian Household Health Survey known as Riskesdas. Level of disability obtained from two main population groups: those with and without non communicable disease (NCD). They then divided by age. The World Health Organization Disability Assessment Schedule II (WHODASII) was used to measure disability. Results: contribution of NCD on disability is obvious among older age indicated by higher proportion of disability with NCD. While risk of disability among younger age is unclear, since disability with NCDproportion is lower than disability without NCD. Probably risk of disability among younger age is other than NCD. None of the groups had members with extreme disability on their global WHO-DASII scores. The analysis identifi es target groups for each stakeholder to develop program for people with disability to reach their maximum potential. Abstrak Penanganan penduduk dengan disabilitas membutuhkan keterlibatan lintas kementerian. Diperlukan informasi besar masalah penduduk dengan disabilitas di Indonesia. Analisa bertujuan mengetahui besaran masalah. Metode: analisa deskriptif univariat dan bivariat data disabilitas Riskesdas 2013 untuk memperoleh Informasi disabilitas seluruh penduduk. Selanjutnya dilakukan analisa besaran disabilitas pada penduduk dengan dan tanpa Penyakit Tidak Menular (PTM). Kelompok ini kemudian digolongkan menurut umur. Instrumen The World Health Organization Disability Assessment Schedule II (WHO-DASII) digunakan untuk mengukur disabilitas. Hasil: 18% penduduk Indonesia mengalami disabilitas. Informasi lebih rinci 8,2% mengalami kesulitan ringan, 6,8% kesulitan sedang dan 3% kesulitan berat. Kontribusi PTM terhadap disabilitas terlihat jelas pada kelompok usia 45 tahun atau lebih ditunjukkan dengan lebih tingginya proporsi disabilitas dengan PTM. Sedangkan risiko disabilitas pada kelompok usia sebelum 45 tahun bukan PTM, karena proporsidisabilitas dengan PTM lebih rendah.


2003 ◽  
Vol 7 (1) ◽  
Author(s):  

The European Programme for Intervention Epidemiology Training (EPIET) started in 1995. The programme is funded by the European Commission and by various European Union (EU) member states as well as Norway and the World Health Organization (WHO). Subject to agreement for another round of funding, the ninth cohort of fellows will start in October 2003. The programme invites applications for 10 fellowships for this 24 month training programme in communicable disease field epidemiology.


2008 ◽  
Vol 29 (2) ◽  
pp. 84
Author(s):  
Tony Della-Porta ◽  
Michael Catton

The World Health Organization (WHO) Collaborating Centre for Biosafety in Microbiology has been established at the Victorian Infectious Diseases Reference Laboratory (VIDRL) for over 2 decades and played a significant role in the development of the WHO Laboratory Biosafety Manual and the WHO Biorisk Guidelines. It has also contributed to WHO?s international biosafety programmes and to the raising awareness of biosafety in Australia.


2020 ◽  
Vol 8 ◽  
Author(s):  
Malik Aydin ◽  
Ella A. Naumova ◽  
Soeren Lutz ◽  
Almut Meyer-Bahlburg ◽  
Wolfgang H. Arnold ◽  
...  

In summer 2017, the World Health Organization published 10 facts on asthma, which is known as a major non-communicable disease of high clinical and scientific importance with currently several hundred million people—with many children among them—suffering from air passages inflammation and narrowing. Importantly, the World Health Organization sees asthma as being underdiagnosed and undertreated. Consequently, much more efforts in clinical disease management and research need to be spent on reducing the asthma-related health burden. Particularly, for young approximately 6 months aged patients presenting recurrent bronchitic respiratory symptoms, many parents anxiously ask the doctors for risk prognosis for their children's future life. Therefore, we urgently need to reevaluate if the current diagnostic and treatment measures are in concordance with our yet incomplete knowledge of pathomechanisms on exacerbation. To contribute to this increasing concern worldwide, we established a multicentric pediatric exacerbation study network, still recruiting acute exacerbated asthmatics (children >6 years) and preschool asthmatics/wheezers (children <6 years) since winter 2018 in Germany. The current study that has a currently population comprising 176 study participants aims to discover novel holistic entry points for achieving a better understanding of the poorly understood plasticity of involved molecular pathways and to define biomarkers enabling improved diagnostics and therapeutics. With this study description, we want to present the study design, population, and few ongoing experiments for novel biomarker research.Clinical Trial Registration: German Clinical Trials Register (Deutsches Register für Klinische Studien, DRKS): DRKS00015738.


Author(s):  
GANGAPRASAD ANANTRAO WAGHMARE

 Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death   Initially, the World Health Organization (WHO) had mentioned 2% as a mortality rate estimate in a press conference on Wednesday, January 29 and again on February 10. However, on January 29 2020 WHO specified that this was a very early and provisional estimate that might have changed. 3.4% Mortality Rate estimate by the World Health Organization (WHO) as of March 3 2020.                           The concept of epidemic was very much well defined in Ayurveda, Acharya Charaka the great physician of all ages had mentioned the epidemic diseases under the heading of “Janapadodhwans”.The aim of this review study is to understand the ancient Ayurveda epidemic literature , to prevent people from getting affected by epidemic diseases and to enlighten on epidemic diseases prevention & Management through Ayurveda. Keywords: Novel corona Virus (2019-nCoV),severe acute respiratory syndrome,Janapadodhwans,Ayurveda,epidemic Diseases,communicable disease,Panchakarma, Rasayan .  


Epidemics of smallpox, cholera, plague and other infectious diseases in the world in the past were accompanied by the deaths of millions of people and often threatened humanity with destruction as a biological species. Therefore, society was forced to join forces to create an organization that would provide health protection on a global scale. On April 7, 1948, 26 UN member states created the World Health Organization, the main goal of which was to help provide the protection of health of the population of all countries of the world. Purpose of the study - analysis of the historical data of the process of creating the World Health Organization, achievements for all the years of its existence, financing in last years and formation of the opinions of authors on the role of this organization in solving health problems of all humanity. Results. The article presents data on stages of the formation of the World Health Organization. Information about positive results for more than 70 years in solving reproductive health problems, maternal and child mortality, eradicating many infectious diseases in different parts of the world and other problems is detailed. Joint resolutions of the World Health Organization with the United Nations were adopted about general and complete disarmament, protection of humanity from atomic radiation, ban on the use of chemical and bacteriological weapons, defining of the role of doctors and other health workers in the preservation and strengthening of the world. Information on the World Health Organization funding is provided. The prospects for the development of the organization are described. Conclusions. The World Health Organization actively continues its work – maintains contact with international experts, governments and partners for quick collection of scientific data on a new virus, tracks its distribution and assesses its virulence, provides to countries and population recommendations on health protection measures and preventing the spread of infection. The global climatic crisis and the coronavirus infection pandemic showed that the role of the World Health Organization should increase to prevent cataclysms in some countries and globally. It is the World Health Organization that has a huge positive international experience in fighting various public health problems and it remains the only effective organization that consolidates the efforts of most countries of the world to overcome the problems of all humanity.


2021 ◽  
Vol 1 (4) ◽  
pp. 140-151
Author(s):  
Dilyara Syunyakova

Migration issues, including the impact of migrant flows on the state of public health in the host country and infectious diseases imported by migrants are currently causing much debate. The aim of this study is to analyze data on the prevalence of infectious diseases among migrants and measures to reduce infectious morbidity taken in the countries of the Greater Mekong Subregion, also referred by the World Health Organization (WHO) to the South-East Asia and Western Pacific regions. The research materials included reports, statistical materials, program documents by the World Health Organization, the International Organization for Migration, and other publications. To analyze the situation with infectious diseases among migrants, we selected materials containing information and statistics on infectious diseases in the countries of the Greater Mekong subregion (China, Thailand, Cambodia, Laos, Vietnam, also included in the group countries of the Greater Mekong subregion), since it is in these countries that migration flows are very intense and the problem of transmission of infectious diseases from migrants to the population of the host countries is very urgent. Despite the lack of available statistical information on the level of infectious morbidity among migrants in the countries of the WHO regions of South-East Asia and the Western Pacific, as well as different migration and social policies in these countries, the results obtained allow us to conclude that the special programs and measures to reduce morbidity among migrants are yielding positive results. Screening and testing for infectious diseases in migrants, as well as an appropriate social policy in terms of providing universal health insurance for refugees and migrants, would make it possible to timely diagnose infectious diseases in migrants and thus contribute to a decrease in their incidence and, accordingly, the incidence of persistent diseases. the population of the host countries.


Author(s):  
Gian Luca Burci

This article reviews the main international and institutional legal aspects of cooperation in the fight against the plague of infectious diseases. It makes a particular reference to the role of the World Health Organization (WHO) and other agencies of the UN system. This article underscores the intrinsically international dimension of the realization of the essential importance of international cooperation.


Sign in / Sign up

Export Citation Format

Share Document